Research view

Title: Zuclopenthixol: a new generation of antipsychotic drugs. An open clinical trial.
Author: Matar AM, Abdel-Mawgoud M, Skov S.
Abstract:
Fifteen patients (20-49 years of age) with mania or acute psychosis were treated with zuclopenthixol acetate (Clopixol, Acuphase). One injection of 75-100 mg produced significant amelioration of psychotic symptoms with minimal side effects. The duration o
Journal: J Clin Psychopharmacol. 1990 Aug;10(4):283-6.